Announcing the "Portable Expiratory CO Concentration Measuring Device Integrated Therapeutic Application" IoT Device.
We have developed the "Portable Expiratory CO Concentration Measuring Device Integrated Therapeutic Application" IoT Device to allow for the measurement of exhaled carbon monoxide (CO) concentrations in smoking cessation treatments in the field of telemedicine. In recent years, the government's Future Investment Conference and the Ministry of Health, Labor and Welfare have been discussing about the expansion of insurance applications to telemedicine. Smoking cessation therapy has become a hot topic. One of the challenges have been that one of the main conditions for the current insurance application, the measurement of the carbon monoxide (CO) concentration in breath, cannot be performed remotely. Patients must attend a medical facility to obtain these results. We are proud to announce that CureApp Inc. (Headquarters: Chuo-ku, Tokyo, President and CEO: Kota Satake) offers a "portable IoT device" that enables patients to measure breath CO concentrat